13D Filing: James E. Flynn and DFB Healthcare Acquisitions Corp.

Page 15 of 18

Page 15 of 18 – SEC Filing

Cusip No. 23291E208 15 of
15 Pages

The foregoing summaries of certain terms of the Letter Agreement,
Registration Rights Agreement, Warrant Agreement, Warrant Purchase Agreement and the LLC Agreement are not complete and are qualified
in their entirety by reference to the full text of such documents, copies of which are filed, or incorporated by reference, as Exhibits
1-5 to this Schedule 13D.

Item 7. Material to be Filed as Exhibits.
Exhibit 1 Letter Agreement, dated February 15, 2018, by and between DFB Healthcare Acquisitions Corp. and Deerfield
Private Design Fund IV, L.P. (incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K filed
with the SEC on February 22, 2018).

Exhibit 2

Registration Rights Agreement, dated as of February 15, 2018, between the DFB Healthcare Acquisitions
Corp., Deerfield/RAB Ventures, LLC and the Initial Stockholders (incorporated by reference to Exhibit 10.3 to the Company’s
Current Report on Form 8-K filed with the SEC on February 22, 2018). 

Exhibit 3

Warrant Agreement, dated February 15, 2018, between DFB Healthcare Acquisitions Corp. and Continental
Stock Transfer & Trust Company (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K
filed with the SEC on February 22, 2018). 

Exhibit 4

Warrant Agreement, dated February 15, 2018, between DFB Healthcare Acquisitions Corp. and Deerfield/RAB
Ventures, LLC (incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K filed with the SEC on
February 22, 2018). 

Exhibit 5

Limited Liability Company Agreement of Deerfield/RAB Ventures, LLC, dated as of February 15, 2018, by
and between RAB Ventures (DFB) LLC and Deerfield Private Design Fund IV, L.P. *

Exhibit 99.1

Joint Filing Agreement dated as of March 5, 2018 by and among the Reporting Persons.*

Exhibit 99.2

Power of Attorney previously filed as Exhibit 24 to a Form 3 with regard to Proteon Therapeutics, Inc.
filed with the Securities and Exchange Commission on August 4, 2017 by Deerfield Special Situations Fund, L.P., Deerfield Partners,
L.P., Deerfield International Master Fund, L.P., Deerfield Private Design Fund III, L.P., Deerfield Private Design Fund IV, L.P.,
Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Management Company, L.P., and James E. Flynn.

* Filed herewith.

Follow Adapthealth Corp.

Page 15 of 18